IKENA ONCOLOGY INC (IKNA) Stock Overview
NASDAQ:IKNA - US45175G1085 - Common Stock
IKNA Key Statistics, Chart & Performance
The current stock price of IKNA is 1.43 USD. In the past month the price increased by 6.72%. In the past year, price decreased by -15.88%.
IKNA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 45.36 | 693.36B | ||
| JNJ | JOHNSON & JOHNSON | 17.72 | 426.69B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 14.48 | 250.88B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 18 | 247.73B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 14.3 | 244.98B | ||
| MRK | MERCK & CO. INC. | 10.92 | 210.11B | ||
| PFE | PFIZER INC | 7.3 | 140.77B | ||
| SNY | SANOFI-ADR | 11.17 | 120.68B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 7.01 | 96.03B | ||
| GSK | GSK PLC-SPON ADR | 8.8 | 79.92B | ||
| ZTS | ZOETIS INC | 25.14 | 69.31B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 51.69 | 47.34B |
Related stock screener links
About IKNA
Company Profile
Ikena Oncology, Inc. is a clinical stage biotechnology company, which engages in the development of patient directed and biomarker driven therapies for cancer patients. The company is headquartered in Boston, Massachusetts and currently employs 10 full-time employees. The company went IPO on 2021-03-26. The firm is focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance. Its lead program in the RAS pathway, IK-595, is a molecular glue designed to trap MEK and RAF in an inactive complex, more completely inhibiting RAS signals than existing inhibitors. IK-595’s ability to complex the RAFs, including CRAF prevents a signaling bypass mechanism that cancer cells employ to drive therapeutic resistance to other drugs in this class. IK-595 is being developed as an oral therapy and evaluated in a Phase I clinical trial in RAS and RAF mutant cancers.
Company Info
IKENA ONCOLOGY INC
50 Northern Ave.
Boston MASSACHUSETTS 02210 US
CEO: Mark Manfredi
Employees: 18
Phone: 18573438292
IKENA ONCOLOGY INC / IKNA FAQ
What is the stock price of IKENA ONCOLOGY INC today?
The current stock price of IKNA is 1.43 USD. The price increased by 4.38% in the last trading session.
What is the ticker symbol for IKENA ONCOLOGY INC stock?
The exchange symbol of IKENA ONCOLOGY INC is IKNA and it is listed on the Nasdaq exchange.
On which exchange is IKNA stock listed?
IKNA stock is listed on the Nasdaq exchange.
What is IKENA ONCOLOGY INC worth?
IKENA ONCOLOGY INC (IKNA) has a market capitalization of 15.99M USD. This makes IKNA a Nano Cap stock.
How many employees does IKENA ONCOLOGY INC have?
IKENA ONCOLOGY INC (IKNA) currently has 18 employees.
What are the support and resistance levels for IKENA ONCOLOGY INC (IKNA) stock?
IKENA ONCOLOGY INC (IKNA) has a support level at 1.34 and a resistance level at 1.44. Check the full technical report for a detailed analysis of IKNA support and resistance levels.
Should I buy IKENA ONCOLOGY INC (IKNA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IKNA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IKNA, evaluating the profitability, health, valuation and growth aspects
- IKENA ONCOLOGY INC (IKNA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- IKENA ONCOLOGY INC (IKNA) Sales and EPS estimates to see what analysts future expectations are.
- IKENA ONCOLOGY INC (IKNA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- IKENA ONCOLOGY INC (IKNA) Insider and Institutional Ownership to learn about the owners and their transactions.
- IKENA ONCOLOGY INC (IKNA) Stock Chart to make your own analysis
- IKENA ONCOLOGY INC (IKNA) Latest news and press-releases to stay up to date.
Does IKENA ONCOLOGY INC (IKNA) stock pay dividends?
IKNA does not pay a dividend.
When does IKENA ONCOLOGY INC (IKNA) report earnings?
IKENA ONCOLOGY INC (IKNA) will report earnings on 2025-11-05, before the market open.
What is the Price/Earnings (PE) ratio of IKENA ONCOLOGY INC (IKNA)?
IKENA ONCOLOGY INC (IKNA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.28).
IKNA Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to IKNA. When comparing the yearly performance of all stocks, IKNA turns out to be only a medium performer in the overall market: it outperformed 47.83% of all stocks.
IKNA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to IKNA. No worries on liquidiy or solvency for IKNA as it has an excellent financial health rating, but there are worries on the profitability.
IKNA Financial Highlights
Over the last trailing twelve months IKNA reported a non-GAAP Earnings per Share(EPS) of -3.28. The EPS decreased by -121.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -34.79% | ||
| ROE | -39.1% | ||
| Debt/Equity | 0 |